You are here

Ascletis Pharma

Ascletis' swift surge into obesity continues with competitive oral GLP-1 data

Fierce Biotech

Wed, 02/19/25 - 09:47 pm

Ascletis Pharma

clinical trials

Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial

Clinical Trials Arena

Tue, 01/21/25 - 11:27 am

Ascletis Pharma

clinical trials

Spotlight – Nash in 2023 and beyond

EP Vantage

Thu, 08/3/23 - 10:03 am

Boehringer Ingelheim

Akero Therapeutics

Ionis Pharmaceuticals

Gilead Sciences

Ascletis Pharma